111 related articles for article (PubMed ID: 11457859)
1. Differential binding of an SRF/NK-2/MEF2 transcription factor complex in normal versus neoplastic smooth muscle tissues.
Phiel CJ; Gabbeta V; Parsons LM; Rothblat D; Harvey RP; McHugh KM
J Biol Chem; 2001 Sep; 276(37):34637-50. PubMed ID: 11457859
[TBL] [Abstract][Full Text] [Related]
2. The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor.
Carson JA; Fillmore RA; Schwartz RJ; Zimmer WE
J Biol Chem; 2000 Dec; 275(50):39061-72. PubMed ID: 10993896
[TBL] [Abstract][Full Text] [Related]
3. Telokin expression in A10 smooth muscle cells requires serum response factor.
Herring BP; Smith AF
Am J Physiol; 1997 Apr; 272(4 Pt 1):C1394-404. PubMed ID: 9142867
[TBL] [Abstract][Full Text] [Related]
4. A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes.
Nishida W; Nakamura M; Mori S; Takahashi M; Ohkawa Y; Tadokoro S; Yoshida K; Hiwada K; Hayashi K; Sobue K
J Biol Chem; 2002 Mar; 277(9):7308-17. PubMed ID: 11744740
[TBL] [Abstract][Full Text] [Related]
5. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development.
Creemers EE; Sutherland LB; McAnally J; Richardson JA; Olson EN
Development; 2006 Nov; 133(21):4245-56. PubMed ID: 17021041
[TBL] [Abstract][Full Text] [Related]
6. Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells.
Li L; Liu Z; Mercer B; Overbeek P; Olson EN
Dev Biol; 1997 Jul; 187(2):311-21. PubMed ID: 9242426
[TBL] [Abstract][Full Text] [Related]
7. Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells.
Strobeck M; Kim S; Zhang JC; Clendenin C; Du KL; Parmacek MS
J Biol Chem; 2001 May; 276(19):16418-24. PubMed ID: 11279108
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y).
Chin MT; Pellacani A; Wang H; Lin SS; Jain MK; Perrella MA; Lee ME
J Biol Chem; 1998 Apr; 273(16):9755-60. PubMed ID: 9545312
[TBL] [Abstract][Full Text] [Related]
9. Serum response factor-dependent regulation of the smooth muscle calponin gene.
Miano JM; Carlson MJ; Spencer JA; Misra RP
J Biol Chem; 2000 Mar; 275(13):9814-22. PubMed ID: 10734136
[TBL] [Abstract][Full Text] [Related]
10. Identification of Barx2b, a serum response factor-associated homeodomain protein.
Herring BP; Kriegel AM; Hoggatt AM
J Biol Chem; 2001 Apr; 276(17):14482-9. PubMed ID: 11278942
[TBL] [Abstract][Full Text] [Related]
11. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.
Anderson JP; Dodou E; Heidt AB; De Val SJ; Jaehnig EJ; Greene SB; Olson EN; Black BL
Mol Cell Biol; 2004 May; 24(9):3757-68. PubMed ID: 15082771
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.
Belaguli NS; Zhou W; Trinh TH; Majesky MW; Schwartz RJ
Mol Cell Biol; 1999 Jul; 19(7):4582-91. PubMed ID: 10373507
[TBL] [Abstract][Full Text] [Related]
13. Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D.
Slepak TI; Webster KA; Zang J; Prentice H; O'Dowd A; Hicks MN; Bishopric NH
J Biol Chem; 2001 Mar; 276(10):7575-85. PubMed ID: 11096067
[TBL] [Abstract][Full Text] [Related]
14. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages.
Kim S; Ip HS; Lu MM; Clendenin C; Parmacek MS
Mol Cell Biol; 1997 Apr; 17(4):2266-78. PubMed ID: 9121477
[TBL] [Abstract][Full Text] [Related]
15. Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx-2.5, and intact serum response elements.
Chen CY; Croissant J; Majesky M; Topouzis S; McQuinn T; Frankovsky MJ; Schwartz RJ
Dev Genet; 1996; 19(2):119-30. PubMed ID: 8900044
[TBL] [Abstract][Full Text] [Related]
16. Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor.
Camoretti-Mercado B; Liu HW; Halayko AJ; Forsythe SM; Kyle JW; Li B; Fu Y; McConville J; Kogut P; Vieira JE; Patel NM; Hershenson MB; Fuchs E; Sinha S; Miano JM; Parmacek MS; Burkhardt JK; Solway J
J Biol Chem; 2000 Sep; 275(39):30387-93. PubMed ID: 10866994
[TBL] [Abstract][Full Text] [Related]
17. An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells.
Mericskay M; Parlakian A; Porteu A; Dandré F; Bonnet J; Paulin D; Li Z
Dev Biol; 2000 Oct; 226(2):192-208. PubMed ID: 11023680
[TBL] [Abstract][Full Text] [Related]
18. Evolutionarily conserved promoter region containing CArG*-like elements is crucial for smooth muscle myosin heavy chain gene expression.
Zilberman A; Dave V; Miano J; Olson EN; Periasamy M
Circ Res; 1998 Mar; 82(5):566-75. PubMed ID: 9529161
[TBL] [Abstract][Full Text] [Related]
19. Serum response factor and protein-mediated DNA bending contribute to transcription of the dystrophin muscle-specific promoter.
Galvagni F; Lestingi M; Cartocci E; Oliviero S
Mol Cell Biol; 1997 Mar; 17(3):1731-43. PubMed ID: 9032300
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex.
Mack CP; Thompson MM; Lawrenz-Smith S; Owens GK
Circ Res; 2000 Feb; 86(2):221-32. PubMed ID: 10666419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
